Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Psychiatry Neurosci ; 46(5): E548-E558, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34625487

ABSTRACT

BACKGROUND: Maraviroc is an antiretroviral agent and C-C chemokine coreceptor 5 (CCR5) antagonist that is currently used to treat human immunodeficiency virus. CCR5/µ-opioid receptor heterodimerization suggests that maraviroc could be a treatment for oxycodone abuse. We treated rats with maraviroc to explore its effect on oxycodone-seeking and its interference with the analgesic effects of oxycodone. We used resting-state blood-oxygen-level-dependent functional connectivity to assess the effect of maraviroc on oxycodone-enhanced coupling in the reward circuitry and performed behavioural tests to evaluate the effect of maraviroc on oxycodone rewarding properties and on oxycodone-seeking after prolonged abstinence. METHODS: Two groups of rats were exposed to 8 consecutive days of oxycodone-conditioned place preference training and treatment with maraviroc or vehicle. Two additional groups were trained to self-administer oxycodone for 10 days and then tested for drug seeking after 14 days of abstinence with or without daily maraviroc treatment. We tested the effects of maraviroc on oxycodone analgesia using a tail-flick assay. We analyzed resting-state functional connectivity data using a rat 3-dimensional MRI atlas of 171 brain areas. RESULTS: Maraviroc significantly decreased conditioned place preference and attenuated oxycodone-seeking behaviour after prolonged abstinence. The analgesic effect of oxycodone was maintained after maraviroc treatment. Oxycodone increased functional coupling with the accumbens, ventral pallidum and olfactory tubercles, but this was reduced with maraviroc treatment. LIMITATIONS: All experiments were performed in male rats only. CONCLUSION: Maraviroc treatment attenuated oxycodone-seeking in abstinent rats and reduced functional coupling in the reward circuitry. The analgesic effects of oxycodone were not affected by maraviroc.


Subject(s)
Anti-HIV Agents/pharmacology , Anti-HIV Agents/therapeutic use , Behavior, Animal/drug effects , Maraviroc/pharmacology , Maraviroc/therapeutic use , Opioid-Related Disorders/drug therapy , Oxycodone/adverse effects , Analgesics, Opioid/adverse effects , Animals , Magnetic Resonance Imaging , Male , Rats
2.
Brain Res Bull ; 165: 218-227, 2020 12.
Article in English | MEDLINE | ID: mdl-33053434

ABSTRACT

BACKGROUND: Does minor head impact without signs of structural brain damage cause short-term changes in vasogenic edema as measured by an increase apparent diffusion coefficient (ADC) using diffusion weighted imaging? If so, could the increase in vasogenic edema be treated with a vasopressin V1a receptor antagonist? We hypothesized that SRX251, a highly selective V1a antagonist, would reduce vasogenic edema in response to a single minor head impact. METHODS: Lightly anesthetized male rats were subjected to a sham procedure or a single hit to the forehead using a closed skull, momentum exchange model. Animals recovered in five min and were injected with saline vehicle (n = 8) or SRX251 (n = 8) at 15 min post head impact and again 7-8 hrs later. At 2 h, 6 h, and 24 h post injury, rats were anesthetized and scanned for increases in ADC, a neurological measure of vasogenic edema. Sham rats (n = 6) were exposed to anesthesia and scanned at all time points but were not hit or treated. Images were registered to and analyzed using a 3D MRI rat atlas providing site-specific data on 150 different brain areas. These brain areas were parsed into 11 major brain regions. RESULTS: Untreated rats with brain injury showed a significant increase in global brain vasogenic edema as compared to sham and SRX251 treated rats. Edema peaked at 6 h in injured, untreated rats in three brain regions where changes in ADC were observed, but returned to sham levels by 24 h. There were regional variations in the time course of vasogenic edema and drug efficacy. Edema was significantly reduced in cerebellum and thalamus with SRX251 treatment while the basal ganglia did not show a response to treatment. CONCLUSION: A single minor impact to the forehead causes regional increases in vasogenic edema that peak at 6 h but return to baseline within a day in a subset of brain regions. Treatment with a selective V1a receptor antagonist can reduce much of the edema.


Subject(s)
Antidiuretic Hormone Receptor Antagonists/therapeutic use , Brain Edema/drug therapy , Brain/drug effects , Head Injuries, Closed/complications , Animals , Antidiuretic Hormone Receptor Antagonists/pharmacology , Brain/diagnostic imaging , Brain Edema/diagnostic imaging , Brain Edema/etiology , Disease Models, Animal , Head Injuries, Closed/diagnostic imaging , Magnetic Resonance Imaging , Male , Rats , Rats, Sprague-Dawley
3.
Neurosci Lett ; 714: 134565, 2020 01 01.
Article in English | MEDLINE | ID: mdl-31639422

ABSTRACT

Arginine vasopressin (AVP) is a chemical signal in the brain that influences cerebral vascular resistance and brain water permeability. Increases in AVP contribute to the pathophysiology of brain edema following traumatic brain injury (TBI). These effects are mediated through AVP V1a receptors that are expressed in cortical and subcortical brain areas. This exploratory study characterizes the effects of a novel, V1a receptor antagonist, AVN576, on behavioral and magnetic resonance imaging (MRI) measures after severe TBI. Male Sprague Dawley rats were impacted twice producing contusions in the forebrain, putative cerebral edema, and cognitive deficits. Rats were treated with AVN576 after initial impact for 5 days and then tested for changes in cognition. MRI was used to assess brain injury, enlargement of the ventricles, and resting state functional connectivity. Vehicle treated rats had significant deficits in learning and memory, enlarged ventricular volumes, and hypoconnectivity in hippocampal circuitry. AVN576 treatment eliminated the enlargement of the lateral ventricles and deficits in cognitive function while increasing connectivity in hippocampal circuitry. These data corroborate the extensive literature that drugs selectively targeting the AVP V1a receptor could be used to treat TBI in the clinic.


Subject(s)
Antidiuretic Hormone Receptor Antagonists/pharmacology , Brain Contusion/diagnostic imaging , Brain Edema/diagnostic imaging , Brain/drug effects , Cognition/drug effects , Animals , Behavior, Animal/drug effects , Brain/diagnostic imaging , Brain/physiopathology , Brain Contusion/complications , Brain Contusion/drug therapy , Brain Contusion/physiopathology , Brain Edema/etiology , Brain Edema/physiopathology , Brain Injuries, Traumatic/complications , Brain Injuries, Traumatic/diagnostic imaging , Brain Injuries, Traumatic/drug therapy , Brain Injuries, Traumatic/physiopathology , Functional Neuroimaging , Hippocampus/diagnostic imaging , Hippocampus/physiopathology , Lateral Ventricles/diagnostic imaging , Lateral Ventricles/pathology , Magnetic Resonance Imaging , Maze Learning , Organ Size , Rats , Receptors, Vasopressin
4.
Brain Res ; 1747: 147030, 2020 11 15.
Article in English | MEDLINE | ID: mdl-32745658

ABSTRACT

The APOE Ɛ4 genotype is the most prevalent genetic risk for Alzheimer's disease (AD). Women carriers of Ɛ4 have higher risk for an early onset of AD than men. Human imaging studies suggest apolipoprotein Ɛ4 may affect brain structures associated with cognitive decline in AD many years before disease onset. It was hypothesized that female APOE Ɛ4 carriers would present with decreased cognitive function and neuroradiological evidence of early changes in brain structure and function as compared to male carriers. Six-month old wild-type (WT) and human APOE Ɛ4 knock-in (TGRA8960), male and female Sprague Dawley rats were studied for changes in brain structure using voxel-based morphometry, alteration in white and gray matter microarchitecture using diffusion weighted imaging with indices of anisotropy, and functional coupling using resting state BOLD functional connectivity. Images from each modality were registered to, and analyzed, using a 3D MRI rat atlas providing site-specific data on over 168 different brain areas. Quantitative volumetric analysis revealed areas involved in memory and arousal were significantly different between Ɛ4 and wild-type (WT) females, with few differences between male genotypes. Diffusion weighted imaging showed few differences between WT and Ɛ4 females, while male genotypes showed significant different measures in fractional anisotropy and apparent diffusion coefficient. Resting state functional connectivity showed Ɛ4 females had greater connectivity between areas involved in cognition, emotion, and arousal compared to WT females, with male Ɛ4 showing few differences from controls. Interestingly, male Ɛ4 showed increased anxiety and decreased performance in spatial and episodic memory tasks compared to WT males, with female genotypes showing little difference across behavioral tests. The sex differences in behavior and diffusion weighted imaging suggest male carriers of the Ɛ4 allele may be more vulnerable to cognitive and emotional complications compared to female carriers early in life. Conversely, the data may also suggest that female carriers are more resilient to cognitive/emotional problems at this stage of life perhaps due to altered brain volumes and enhanced connectivity.


Subject(s)
Apolipoprotein E4/genetics , Brain/diagnostic imaging , Animals , Arousal/physiology , Cognition/physiology , Emotions/physiology , Female , Gene Knock-In Techniques , Genotype , Magnetic Resonance Imaging , Male , Memory/physiology , Rats , Rats, Sprague-Dawley , Rats, Transgenic , Sex Characteristics
5.
Front Syst Neurosci ; 13: 34, 2019.
Article in English | MEDLINE | ID: mdl-31427931

ABSTRACT

OBJECTIVES: To test the hypothesis that there are differences in neuroradiological measures between single and repeated mild traumatic brain injury using multimodal MRI. METHODS: A closed-head momentum exchange model was used to produce one or three mild head injuries in young adult male rats compared to non-injured, age and weight-matched controls. Six-seven weeks post-injury, rats were studied for deficits in cognitive and motor function. Seven-eight weeks post-injury changes in brain anatomy and function were evaluated through analysis of high resolution T2 weighted images, resting-state BOLD functional connectivity, and diffusion weighted imaging with quantitative anisotropy. RESULTS: Head injuries occurred without skull fracture or signs of intracranial bleeding or contusion. There were no significant differences in cognitive or motors behaviors between experimental groups. With a single mild hit, the affected areas were limited to the caudate/putamen and central amygdala. Rats hit three times showed altered diffusivity in white matter tracts, basal ganglia, central amygdala, brainstem, and cerebellum. Comparing three hits to one hit showed a similar pattern of change underscoring a dose effect of repeated head injury on the brainstem and cerebellum. Disruption of functional connectivity was pronounced with three mild hits. The midbrain dopamine system, hippocampus, and brainstem/cerebellum showed hypoconnectivity. Interestingly, rats exposed to one hit showed enhanced functional connectivity (or hyperconnectivity) across brain sites, particularly between the olfactory system and the cerebellum. INTERPRETATION: Neuroradiological evidence of altered brain structure and function, particularly in striatal and midbrain dopaminergic areas, persists long after mild repetitive head injury. These changes may serve as biomarkers of neurodegeneration and risk for dementia later in life.

6.
Neuroscience ; 398: 88-101, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30550747

ABSTRACT

The present study was designed to use blood-oxygen-level dependent (BOLD) imaging to "fingerprint" the change in activity in response to oxycodone (OXY) in drug naïve rats before and after repeated exposure to OXY. It was hypothesized that repeated exposure to OXY would initiate adaptive changes in brain organization that would be reflected in an altered response to opioid exposure. Male rats exposed to OXY repeatedly showed conditioned place preference, evidence of drug-seeking behavior and putative neuroadaptation. As these studies were done on awake rats we discovered it was not possible to image rats continuously exposed to OXY due to motion artifact judged to be withdrawal while in the scanner. To circumvent this problem manganese-enhanced MRI (MEMRI) was used to map the distributed integrated activity pattern resulting from continuous OXY exposure. Rats were administered OXY (2.5 mg/kg, i.p.) during image acquisition and changes in BOLD signal intensity were recorded and the activation and deactivation of integrated neural circuits involved in olfaction and motivation were identified. Interestingly, the circuitry of the mesencephalic dopaminergic system showed little activity to the first exposure of OXY. In the MEMRI study, rats received OXY treatments (2.5 mg/kg, twice daily) for four consecutive days following intraventricular MnCl2. Under isoflurane anesthesia, T1-weighted images were acquired and subsequently analyzed showing activity in the forebrain limbic system, ventral striatum, accumbens, amygdala and hippocampus. These results show brain activity is markedly different when OXY is presented to drug naïve rats versus rats with prior, repeated exposure to drug.


Subject(s)
Brain/drug effects , Brain/diagnostic imaging , Oxycodone/administration & dosage , Psychotropic Drugs/administration & dosage , Animals , Brain/physiopathology , Brain Mapping , Cerebrovascular Circulation/drug effects , Conditioning, Psychological/drug effects , Conditioning, Psychological/physiology , Drug-Seeking Behavior/drug effects , Drug-Seeking Behavior/physiology , Magnetic Resonance Imaging , Male , Neural Pathways/diagnostic imaging , Neural Pathways/drug effects , Neural Pathways/physiopathology , Oxygen/blood , Rats, Sprague-Dawley , Reward , Spatial Behavior/drug effects , Spatial Behavior/physiology , Substance-Related Disorders/diagnostic imaging , Substance-Related Disorders/physiopathology , Time Factors
7.
Brain Res ; 1706: 58-67, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30389398

ABSTRACT

Parkinson's Disease (PD) is the second most common neurodegenerative disorder, with 60,000 new cases diagnosed each year in the US. There are multiple animal models of PD that attempt to mimic the effects of the disease through genetic alteration. Combined with advanced imaging techniques, these animal models are critical in tracking the neurobiological and behavioral aspects of disease progression and identifying early biomarkers of PD. PTEN-induced putative kinase 1 (PINK1) is a mitochondrial protein kinase involved in protecting neurons from stress-induced mitochondrial dysfunction. A mutation in the PINK1 gene that alters its function can increase the risk for autosomal recessive familial PD and similarly, through genetic deletion of portions of the PINK1 gene in animal models (i.e., "PINK1 knock-out (-/-) rats) produces a progressive loss of dopaminergic neurons in the substantia nigra which is analogous to the pathological hallmarks in human PD patients. In this exploratory study, we used volumetric analysis, resting-state functional connectivity MRI (rs-fcMRI) and diffusion-weighted imaging (DWI) to identify neurobiological differences between wild-type (WT) and PINK1 (-/-) rats. All voxel-based measures for each modality were registered to a rat MRI atlas with 171 segmented and annotated brain regions allowing for the measurement of subtle changes in brain function and architecture that go well beyond typical clinical MRI scanning protocols. Basal ganglia, the mesencephalic dopamine system, the limbic cortex, and the hippocampal complex showed changes in putative gray matter microarchitecture, reflected by shifts in quantitative anisotropy. Rs-fcMRI revealed altered resting state connectivity in many brain areas including the basal ganglia, amygdala, cortex, septum, pons etc. Taken together, these results inform us on a wide range of whole-brain changes occurring in a PD rat model in the absence of cognitive and motor deficits, serving as potential biomarkers and targets for treatment.


Subject(s)
Gray Matter/metabolism , Parkinson Disease/metabolism , Protein Kinases/metabolism , Animals , Anisotropy , Biomarkers , Brain/metabolism , Diffusion Magnetic Resonance Imaging/methods , Disease Models, Animal , Dopamine/metabolism , Dopaminergic Neurons/metabolism , Magnetic Resonance Imaging/methods , Male , Mitochondria/metabolism , Motor Activity/physiology , Parkinson Disease/pathology , Pilot Projects , Protein Kinases/genetics , Rats , Rats, Long-Evans , Substantia Nigra/metabolism
8.
J Parkinsons Dis ; 8(2): 281-301, 2018.
Article in English | MEDLINE | ID: mdl-29710734

ABSTRACT

BACKGROUND: Genetic models of Parkinson's disease (PD) coupled with advanced imaging techniques can elucidate neurobiological disease progression, and can help identify early biomarkers before clinical signs emerge. PTEN-induced putative kinase 1 (PINK1) helps protect neurons from mitochondrial dysfunction, and a mutation in the associated gene is a risk factor for recessive familial PD. The PINK1 knockout (KO) rat is a novel model for familial PD that has not been neuroradiologically characterized for alterations in brain structure/function, alongside behavior, prior to 4 months of age. OBJECTIVE: To identify biomarkers of presymptomatic PD in the PINK1 -/- rat at 3 months using magnetic resonance imaging techniques. METHODS: At postnatal weeks 12-13; one month earlier than previously reported signs of motor and cognitive dysfunction, this study combined imaging modalities, including assessment of quantitative anisotropy across 171 individual brain areas using an annotated MRI rat brain atlas to identify sites of gray matter alteration between wild-type and PINK1 -/- rats. RESULTS: The olfactory system, hypothalamus, thalamus, nucleus accumbens, and cerebellum showed differences in anisotropy between experimental groups. Molecular analyses revealed reduced levels of glutathione, ATP, and elevated oxidative stress in the substantia nigra, striatum and deep cerebellar nuclei. Mitochondrial genes encoding proteins in Complex IV, along with mRNA levels associated with mitochondrial function and genes involved in glutathione synthesis were reduced. Differences in brain structure did not align with any cognitive or motor impairment. CONCLUSIONS: These data reveal early markers, and highlight novel brain regions involved in the pathology of PD in the PINK1 -/- rat before behavioral dysfunction occurs.


Subject(s)
Brain/metabolism , Parkinson Disease/metabolism , Protein Kinases/metabolism , Adenosine Triphosphate/metabolism , Animals , Brain/diagnostic imaging , DNA Methylation , Disease Models, Animal , Glutathione/metabolism , Learning/physiology , Magnetic Resonance Imaging , Male , Maze Learning/physiology , Motor Activity/physiology , Oxidative Stress/physiology , Parkinson Disease/diagnostic imaging , Parkinson Disease/genetics , Protein Kinases/genetics , Rats , Rats, Long-Evans , Rats, Transgenic , Recognition, Psychology/physiology
9.
Dis Model Mech ; 11(6)2018 06 27.
Article in English | MEDLINE | ID: mdl-29752287

ABSTRACT

RNASET2 deficiency in humans is associated with infant cystic leukoencephalopathy, which causes psychomotor impairment, spasticity and epilepsy. A zebrafish mutant model suggests that loss of RNASET2 function leads to neurodegeneration due to the accumulation of non-degraded RNA in the lysosomes. The goal of this study was to characterize the first rodent model of RNASET2 deficiency. The brains of 3- and 12-month-old RNaseT2 knockout rats were studied using multiple magnetic resonance imaging modalities and behavioral tests. While T1- and T2-weighted images of RNaseT2 knockout rats exhibited no evidence of cystic lesions, the prefrontal cortex and hippocampal complex were enlarged in knockout animals. Diffusion-weighted imaging showed altered anisotropy and putative gray matter changes in the hippocampal complex of the RNaseT2 knockout rats. Immunohistochemistry for glial fibrillary acidic protein (GFAP) showed the presence of hippocampal neuroinflammation. Decreased levels of lysosome-associated membrane protein 2 (LAMP2) and elevated acid phosphatase and ß-N-acetylglucosaminidase (NAG) activities indicated that the RNASET2 knockout rats likely had altered lysosomal function and potential defects in autophagy. Object recognition tests confirmed that RNaseT2 knockout rats exhibited memory deficits. However, the Barnes maze, and balance beam and rotarod tests indicated there were no differences in spatial memory or motor impairments, respectively. Overall, patients with RNASET2 deficiency exhibited a more severe neurodegeneration phenotype than was observed in the RNaseT2 knockout rats. However, the vulnerability of the knockout rat hippocampus as evidenced by neuroinflammation, altered lysosomal function and cognitive defects indicates that this is still a useful in vivo model to study RNASET2 function.


Subject(s)
Endoribonucleases/genetics , Hippocampus/pathology , Memory Disorders/genetics , Memory Disorders/pathology , Neurodegenerative Diseases/genetics , Ribonucleases/genetics , Animals , Anisotropy , Brain Mapping , CRISPR-Cas Systems/genetics , Cognition , Gene Knockout Techniques , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/physiopathology , Humans , Inflammation/pathology , Lysosomes/metabolism , Magnetic Resonance Imaging , Memory Disorders/physiopathology , Motor Activity , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/physiopathology , Organ Size , Rats, Sprague-Dawley
10.
Front Neurosci ; 10: 471, 2016.
Article in English | MEDLINE | ID: mdl-27857679

ABSTRACT

Blood oxygen level dependent (BOLD) imaging in awake mice was used to identify differences in brain activity between wild-type, and Mu (µ) opioid receptor knock-outs (MuKO) in response to oxycodone (OXY). Using a segmented, annotated MRI mouse atlas and computational analysis, patterns of integrated positive and negative BOLD activity were identified across 122 brain areas. The pattern of positive BOLD showed enhanced activation across the brain in WT mice within 15 min of intraperitoneal administration of 2.5 mg of OXY. BOLD activation was detected in 72 regions out of 122, and was most prominent in areas of high µ opioid receptor density (thalamus, ventral tegmental area, substantia nigra, caudate putamen, basal amygdala, and hypothalamus), and focus on pain circuits indicated strong activation in major pain processing centers (central amygdala, solitary tract, parabrachial area, insular cortex, gigantocellularis area, ventral thalamus primary sensory cortex, and prelimbic cortex). Importantly, the OXY-induced positive BOLD was eliminated in MuKO mice in most regions, with few exceptions (some cerebellar nuclei, CA3 of the hippocampus, medial amygdala, and preoptic areas). This result indicates that most effects of OXY on positive BOLD are mediated by the µ opioid receptor (on-target effects). OXY also caused an increase in negative BOLD in WT mice in few regions (16 out of 122) and, unlike the positive BOLD response the negative BOLD was only partially eliminated in the MuKO mice (cerebellum), and in some case intensified (hippocampus). Negative BOLD analysis therefore shows activation and deactivation events in the absence of the µ receptor for some areas where receptor expression is normally extremely low or absent (off-target effects). Together, our approach permits establishing opioid-induced BOLD activation maps in awake mice. In addition, comparison of WT and MuKO mutant mice reveals both on-target and off-target activation events, and set an OXY brain signature that should, in the future, be compared to other µ opioid agonists.

SELECTION OF CITATIONS
SEARCH DETAIL